Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech

Stage II, HER2-positive early breast cancer (EBC) has many treatment options depending on an individual's diagnosis. Allison was 34 when she was diagnosed. She looks back on meeting with her healthcare team to determine the treatment right for her. | Genentech

Felicia is making the most of life even with stage 4, metastatic HER2-positive breast cancer. The outpouring of love and support from her church community empowers her to continue treatment. Watch her video below. #BreastCancerAwarenessMonth | Genentech

Biomarker testing is a critical step to receiving a complete lung cancer diagnosis and may help guide treatment decisions. However, a significant number of people with lung cancer aren’t aware of biomarker testing and don’t know to ask for it. When Nikki received her lung cancer diagnosis, her doctor suggested they test her right away for certain biomarkers such as ALK. Listen to Nikki’s story and learn about the importance of talking to a healthcare provider about biomarker testing. Learn more